NCT06518603View on ClinicalTrials.gov

Caffeine Citrate in Preterm Infants at Risk of Apnea in Zambia

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Premature Infant DiseaseApnea of PrematurityDevelopment, Infant
Interventions
DRUG

Caffeine citrate 20mg/kg/day

Caffeine citrate 20mg/kg/day given orally once daily for 28 days

DRUG

Placebo-Sterile water 1ml/kg/day

Placebo-sterile water 1mg/kg/day given orally once daily for 28 days

Trial Locations (1)

10100

University Teaching Hospital, Lusaka

All Listed Sponsors
collaborator

University Teaching Hospital, Lusaka, Zambia

OTHER

collaborator

Centre for Infectious Disease Research in Zambia

OTHER

lead

University of Alabama at Birmingham

OTHER